VectivBio

Basel, Switzerland

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

$125.0M raised

Oct 2022

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VectivBio raised?

VectivBio has raised $125.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2022.

Who are VectivBio's investors?

VectivBio's investors include Bpifrance, Vivo Capital, TCG Crossover, OrbiMed, Forbion Capital Partners.

Where is VectivBio headquartered?

VectivBio is headquartered in Basel, Switzerland.

What does VectivBio do?

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

What stage is VectivBio at?

VectivBio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 13, 2022.

MLA

"VectivBio — Funding & Investors." VCBacked, October 13, 2022, https://www.vcbacked.co/company/vectivbio. Accessed July 2, 2026.

APA

VCBacked. (2022). VectivBio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vectivbio

Wikipedia (cite web)

{{cite web |title=VectivBio — Funding & Investors |url=https://www.vcbacked.co/company/vectivbio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 13, 2022.